WeVote
Log In

Bill

Bill

HF 4881

Prescription Drug Affordability Advisory Council eliminated, nondepository financial institution provisions modified, health plan regulatory alignment provided, duties transferred, premium security plan modified, appropriations reduced, and money appropriated.

2025-2026 Regular Session Introduced by Erin Koegel

Health plan regulation moves from Health to Commerce and is unified under Commerce oversight.

Introduction and first reading, referred to Rules and Legislative Administration
#appropriations #commercedepartment #insurance-health
0
WeVote Research Nonpartisan
Bill Summary · HF 4881

Summary of HF 4881 (2025-2026) – Minnesota

HF 4881 introduces a package of reforms across health plan regulation, prescription drug affordability, non-depository financial institutions, and health plan regulatory alignment. The bill also contemplates transferring certain regulatory duties, reducing appropriations, and directing new reporting requirements.

Note: This summary focuses on main purposes, key provisions, affected parties, and timeline/process considerations.

1) Overall Purpose and Intent

  • Streamline and reallocate regulatory duties among state agencies (notably moving health plan oversight from Health to Commerce in certain areas).
  • Eliminate the Prescription Drug Affordability Advisory Council and modify related processes for identifying and publishing price information.
  • Reform non-depository financial institution regulation (broadening/clarifying scopes of licensees and activities).
  • Align health plan regulation with a unified Commerce regulatory framework, including transition of duties and personnel.
  • Implement a premium security framework and adjust appropriations accordingly.
  • Require targeted reporting on enrollment growth and health plan market changes.

2) Key Provisions and Changes

A. Health Plan Regulatory Alignment and Transfer of Duties

  • Transfer of health plan regulatory duties from the Department of Health to the Department of Commerce, effective July 1, 2026.
  • Section [60D series] and related cross-references rework governance structure for health carriers and health plans under Commerce oversight.
  • Creation of a regulatory transition pathway, including employee transfers:
    • Health-related staff previously under Health transition to Commerce 30 days after Health approves the transfer.
    • Protections for employee status, representation, and collective bargaining status post-transfer.

B. Health Plan Market Regulation Updates

  • New standards and reporting obligations for health plans:
    • Substantial enrollment growth notification requirement (see 60A.071 below) to inform the commissioner if enrollment grows by more than 35% from the prior year or if specific line-of-business growth exceeds thresholds.
    • Loss ratio and rate filing provisions retained and aligned with Commerce oversight, including public reporting of loss ratios by health plan companies.
    • Short-term coverage provisions continue to be treated distinctly, with phased loss ratio treatment.

C. Premium Security Plan

  • The bill references a Premium Security Plan, but specific legislative language in the provided text centers on regulatory alignment and health plan oversight rather than detailed mechanics of a premium security fund. Expect accompanying sections to:
    • modify or create mechanisms, possibly tied to solvency, reserve requirements, or rate protection, under Commerce oversight.

D. Prescription Drug Affordability Advisory Council Elimination

  • Repeals or repeals-to-be phased-out provisions for the Prescription Drug Affordability Advisory Council.
  • Revisions to definitions and procedures for identifying prescription drugs subject to affordability concerns:
    • Board (now under Commerce) may identify drugs using criteria such as price increases (WAC), thresholds, and CPI adjustments.
    • Public disclosure of identified drug names and price information, with trade-secret protections as appropriate.
  • Repeals two statutory sections (62J.86(2) and 62J.88) related to the advisory council.

E. Non-Depository Financial Institutions Provisions (Commerce)

  • Expanded authority and modernization of non-depository finance regulation:
    • Revisions to authorizations for lenders and mortgage-related activities under 47.20, 47.59, 47.60, 53, 53B, 53C, 56, 58, 58B, 332, 332A, 332B, 62J, 62K, 62L, 62M, and related sections.
    • Inclusion of residential mortgage originators/servicers under chapter 58 within certain lending authorities.
    • Definitions expanded to cover new licensees and activities (e.g., certain sales finance activities under 53C; residential mortgage originators/servicers).
    • Registration and licensing provisions for lenders under 58B.051, annual renewals, and the use of national licensing systems (NMLS) for registration processes.
    • Expanded consumer lending definitions and clarifications of loan, finance charges, APR, and related data disclosures.
  • Virtual currency business activities:
    • New 53B.74 provisions authorizing specific treatment of virtual currency assets for licensee capital calculations and detailed recordkeeping requirements (5-year retention).

F. Health Plan Regulatory and Disclosure Updates

  • Enhanced disclosure requirements for health carriers under 62A.61 (usual and customary fees) to ensure transparency of methodologies used to determine provider reimbursements.

G. Repeals and Reorganizations

  • Repeals effective sections currently tied to the Prescription Drug Affordability Council.
  • Repeals added: 56.08; 332A.02(2); 332B.02(2) in the 2024 statute set.

3) Who/What Is Affected

  • Health plans, health carriers, and health service providers:
    • Subject to Commerce regulatory oversight; potential changes in licensure, filing, and reporting requirements.
  • Department of Health and Department of Commerce:
    • Undergo a major regulatory transfer of health plan oversight duties (and associated staff transfers).
  • Prescription drug pricing and affordability stakeholders:
    • Drug manufacturers, distributors, and public payers/getting price disclosures (while the advisory council is eliminated, price-identification and disclosure duties shift under Commerce).
  • Non-depository financial institutions and lenders:
    • Banks, savings institutions, mortgage originators/servicers, consumer lenders, debt services providers, and related entities.
  • Lenders and debt-related service providers:
    • Registration requirements with Commerce; annual renewals; potential use of NMLS for registration processes.

4) Procedural and Timeline Considerations

  • Effective regulatory transfer: July 1, 2026 (Article 4, Section 15: Regulatory Duties Transfer).
  • Staffing transition: Health employees related to transferred functions move to Commerce 30 days after Health approves the transfer.
  • Enrollee growth reporting:
    • The substantial enrollment growth notification is due by April 15 each year (Section 60A.071, Subdivision 1).
    • Additional information requests may be issued by the commissioner, with potential corrective actions in some scenarios (Subd. 2).
  • Appropriations adjustments:
    • Transfer of health regulatory duties triggers ongoing general fund and state government special revenue reductions in the Department of Health’s appropriations for FY 2027 (Articles 1, Sec. 2).
  • Public disclosure:
    • Price information for identified prescription drugs will be made publicly available, subject to exemptions for proprietary data and trade secrets.
  • Loss ratio reporting:
    • The bill contemplates annual public reporting of loss ratios by health plan companies in coordination with Commerce oversight.

5) Notable Details and Observations

  • The bill consolidates health plan regulation under Commerce, which may affect rate reviews, solvency oversight, and consumer protections.
  • The Prescription Drug Affordability Advisory Council is slated for elimination, with price identification and public disclosure continuing under a revised framework.
  • A broad expansion of non-depository lending regulation includes virtual currency recordkeeping, capital requirements, and licensing modernization.
  • The package includes funding reallocations and ongoing reductions to reflect the transfer of duties.
  • The energy of the bill lies in regulatory modernization and alignment rather than creating wholly new programs, with emphasis on transparency and market oversight.

If you’d like, I can provide a section-by-section annotated map or a comparison against current statutes to highlight exact changes line-by-line.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.